(Q42983412)

12 November 2017

title

Earlier loss of hepatitis C virus RNA in interferon therapy can predict a long-term response in chronic hepatitis C. (English)

1 reference

12 November 2017

1 reference

1 reference

1 reference

Kakumu S

1

1 reference

12 November 2017

Aiyama T

2

1 reference

12 November 2017

Okumura A

3

1 reference

12 November 2017

Iwata K

4

1 reference

12 November 2017

Ishikawa T

5

1 reference

12 November 2017

Yoshioka K

6

1 reference

12 November 2017

publication date

1 June 1997

1 reference

Journal of Gastroenterology and Hepatology

12 November 2017

published in

1 reference

12 November 2017

volume

12

1 reference

12 November 2017

issue

6

1 reference

12 November 2017

page(s)

468-472

1 reference

Detection of hepatitis C virus by polymerase chain reaction and response to interferon-alpha therapy: relationship to genotypes of hepatitis C virus

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Quantitation and typing of serum hepatitis C virus RNA in patients with chronic hepatitis C treated with interferon-beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Prediction of response to interferon treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Lack of benefit of escalating dosage of interferon alfa in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Chronic hepatitis C virus infections: predictive value of genotype and level of viraemia on disease progression and response to interferon alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Hepatic hepatitis C virus RNA as a predictor of a long-term response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Loss of serum HCV RNA at week 4 of interferon‐α therapy is associated with more favorable long‐term response in patients with chronic hepatitis C

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Changes in serum hepatitis C virus RNA titer and response to interferon therapy in patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

A comparison of three interferon alfa-2b regimens for the long-term treatment of chronic non-A, non-B hepatitis. Multicenter Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Increased serum hepatitis C virus RNA levels among alcoholic patients with chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

Hepatic and extrahepatic hepatitis C virus replication in relation to response to interferon therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1440-1746.1997.TB00468.X

10.1111/J.1440-1746.1997.TB00468.X

21 January 2018

Identifiers

DOI

1 reference

12 November 2017

1 reference